Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PANACEA LIFE SCIENCES HOLDINGS, INC.EXDI · Entity 9699 | Director · CHIEF FINANCIAL OFFICER | February 01, 2020 | February 06, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PANACEA LIFE SCIENCES HOLDINGS, INC.
Report date February 01, 2020 · Filed February 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 500,000 |
Reported balance
After 2020-02-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-02-01 · Grant · Acquired 250,000 · Balance 500,000 F1: Consists of 250,000 shares of common stock as reported herein, together with options to purchase 250,000 shares of common stock at a price of $0.20 per share, exercisable until 1/11/29 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 250,000 shares of common stock as reported herein, together with options to purchase 250,000 shares of common stock at a price of $0.20 per share, exercisable until 1/11/29
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2020 Filed Feb 6, 2020 20:07 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000287 · form4-02062020_120208.xml · nonDerivative · entry 1 Puzder Ken · CIK 0001764453 · Director · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F1 · balance_after: Consists of 250,000 shares of common stock as reported herein, together with options to purchase 250,000 shares of common stock at a price of $0.20 per share, exercisable until 1/11/29 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.